Literature DB >> 31219817

Accuracy of Intraoperative Frozen Section of Sentinel Lymph Nodes After Neoadjuvant Chemotherapy for Breast Carcinoma.

Anne Grabenstetter1, Tracy-Ann Moo2, Sabina Hajiyeva1, Peter J Schüffler1, Pallavi Khattar1, Maria A Friedlander1, Maura A McCormack1, Monica Raiss2, Emily C Zabor3, Andrea Barrio2, Monica Morrow2, Marcia Edelweiss1.   

Abstract

False-negative (FN) intraoperative frozen section (FS) results of sentinel lymph nodes (SLN) have been reported to be more common after neoadjuvant chemotherapy (NAC) in the primary surgical setting. We evaluated SLN FS assessment in breast cancer patients treated with NAC to determine the FN rate and the histomorphologic factors associated with FN results. Patients who had FS SLN assessment following NAC from July 2008 to July 2017 were identified. Of the 711 SLN FS cases, 522 were negative, 181 positive, and 8 deferred. The FN rate was 5.4% (28/522). There were no false-positive results. Of the 8 deferred cases, 5 were positive on permanent section and 3 were negative. There was a higher frequency of micrometastasis and isolated tumor cells in FN cases (P<0.001). There was a significant increase in tissue surface area present on permanent section slides compared with FS slides (P<0.001), highlighting the inherent technical limitations of FS and histologic under-sampling of tissue which leads to most FN results. The majority (25/28, 89%) of FN cases had metastatic foci identified exclusively on permanent sections and were not due to a true diagnostic interpretation error. FN cases were more frequently estrogen receptor positive (P<0.001), progesterone receptor positive (P=0.001), human epidermal growth factor receptor-2 negative (P=0.009) and histologic grade 1 (P=0.015), which most likely reflects the lower rates of pathologic complete response in these tumors. Despite its limitations, FS is a reliable modality to assess the presence of SLN metastases in NAC treated patients.

Entities:  

Mesh:

Year:  2019        PMID: 31219817      PMCID: PMC6742561          DOI: 10.1097/PAS.0000000000001311

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  34 in total

1.  Breast cancer molecular subtypes respond differently to preoperative chemotherapy.

Authors:  Roman Rouzier; Charles M Perou; W Fraser Symmans; Nuhad Ibrahim; Massimo Cristofanilli; Keith Anderson; Kenneth R Hess; James Stec; Mark Ayers; Peter Wagner; Paolo Morandi; Chang Fan; Islam Rabiul; Jeffrey S Ross; Gabriel N Hortobagyi; Lajos Pusztai
Journal:  Clin Cancer Res       Date:  2005-08-15       Impact factor: 12.531

2.  Intraoperative examination of sentinel nodes in breast cancer: is the glass half full or half empty?

Authors:  Lucio Fortunato; Mostafà Amini; Massimo Farina; Simonetta Rapacchietta; Leopoldo Costarelli; Francesca R Piro; Giuseppe Alessi; Pierluigi Pompili; Salvatore Bianca; Carlo Eugenio Vitelli
Journal:  Ann Surg Oncol       Date:  2004-11       Impact factor: 5.344

3.  Sentinel lymph nodes in breast cancer after 10 years: rethinking basic principles.

Authors:  Ira J Bleiweiss
Journal:  Lancet Oncol       Date:  2006-08       Impact factor: 41.316

4.  Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy.

Authors:  Bryan T Hennessy; Gabriel N Hortobagyi; Roman Rouzier; Henry Kuerer; Nour Sneige; Aman U Buzdar; Shu Wan Kau; Bruno Fornage; Aysegul Sahin; Kristine Broglio; S Eva Singletary; Vicente Valero
Journal:  J Clin Oncol       Date:  2005-12-20       Impact factor: 44.544

5.  Intraoperative examination of the sentinel lymph node for breast carcinoma staging.

Authors:  R R Turner; N M Hansen; S L Stern; A E Giuliano
Journal:  Am J Clin Pathol       Date:  1999-11       Impact factor: 2.493

6.  Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

Authors:  Eleftherios P Mamounas; Ann Brown; Stewart Anderson; Roy Smith; Thomas Julian; Barbara Miller; Harry D Bear; Christopher B Caldwell; Alonzo P Walker; Wendy M Mikkelson; Jay S Stauffer; Andre Robidoux; Heather Theoret; Atilla Soran; Atilla Sovan; Bernard Fisher; D Lawrence Wickerham; Norman Wolmark
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

7.  Rapid immunohistochemistry for cytokeratin in the intraoperative evaluation of sentinel lymph nodes for metastatic breast carcinoma.

Authors:  Robyn A Beach; Diane Lawson; Sandra M Waldrop; Cynthia Cohen
Journal:  Appl Immunohistochem Mol Morphol       Date:  2003-03

8.  Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18.

Authors:  Edwin R Fisher; Jiping Wang; John Bryant; Bernard Fisher; Eletherios Mamounas; Norman Wolmark
Journal:  Cancer       Date:  2002-08-15       Impact factor: 6.860

9.  Selective intraoperative consultation for the evaluation of sentinel lymph nodes in breast cancer.

Authors:  Paul R Klepchick; David J Dabbs; Marguerite Bonaventura; Jeffrey Falk; Donald Keenan; Douglas Landsittel; Ronald Johnson
Journal:  Am J Surg       Date:  2004-10       Impact factor: 2.565

10.  False-negative frozen section of sentinel lymph node biopsy for breast cancer.

Authors:  S Holck; H Galatius; U Engel; F Wagner; J Hoffmann
Journal:  Breast       Date:  2004-02       Impact factor: 4.380

View more
  3 in total

Review 1.  Evolution of Frozen Section in Carcinoma Breast: Systematic Review.

Authors:  Manjit Kaur Rana; Amrit Pal Singh Rana; Uttam Sharma; Tushar Singh Barwal; Aklank Jain
Journal:  Int J Breast Cancer       Date:  2022-05-23

2.  After neoadjuvant therapy, axillary sentinel lymph node frozen sections from breast cancer patients are accurately diagnosed using telepathology.

Authors:  Valarie McMurtry; Jane M Poretta; Rachel E Factor
Journal:  J Pathol Inform       Date:  2022-03-09

3.  Why Formalin-fixed, Paraffin-embedded Biospecimens Must Be Used in Genomic Medicine: An Evidence-based Review and Conclusion.

Authors:  William Mathieson; Geraldine A Thomas
Journal:  J Histochem Cytochem       Date:  2020-07-22       Impact factor: 2.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.